Method of using a mixture of a phenolic compound and an azole or

Compositions – Leather or fur treating

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

8 941R, 8 9418, C14C 900

Patent

active

058884157

DESCRIPTION:

BRIEF SUMMARY
The present application relates to the use of active compound combinations of phenolic active compounds with azole compounds for the preservation of animal hides and leather.
It is known that phenol derivatives and mixtures or formulations thereof can be used as products for the protection of materials in leather production. However, it has emerged that these compounds, used alone or in combination, do not provide sufficient protection against infections with microbes when storing hides and leather for a prolonged time.
Surprisingly, it has now been found that benzimidazoles, imidazoles, triazoles and/or morpholine derivatives in combination with phenolic compounds allow outstanding, long-term protection of the animal skins and leather during production and storage.
The invention therefore relates to the use of a combination of at least one triazole and/or at least one benzimidazole and/or at least one imidazole and/or at least one morpholine derivative with at least one phenolic compound for the protection of animal hides and leather during production and storage.
Suitable phenolic active compounds are preferably phenol derivatives, such as tribromophenol, trichlorophenol, tetrachlorophenol, nitrophenol, 3-methyl-4-chlorophenol, 3,5-dimethyl-4-chlorophenol, phenoxyethanol, dichlorophene, o-phenylphenol, m-phenylphenol, p-phenylphenol, 2-benzyl-4-chlorophenol, 2,4-dichloro-3,5-dimethylphenol, 4-chlorothymol, chlorphen, triclosan, fentichlor and their ammonium, alkali metal and alkaline earth metal salts, and also their mixtures.
Suitable triazole compounds are preferably triazoles such as amitrole, azocyclotin, azaconazole, BAS 480F, bitertanol, cyproconazole, climbazole, difenoconazole, fenbuconazole, fen-chlorazole, fenethanil, fluquinconazole, flusilazole, flutriafol, hexaconazole, imiben-conazole, isazofos, myclobutanil, metconazole, epoxyconazole, paclobutrazole, penconazole, propiconazole, cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cyclo-heptanol, tebuconazole, 2-(1-tert-butyl)-1 -(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)-propan-2-ol, tetraconazole, triadimefon, triadimenol, triapenthenol, triflumizole, triticonazole, uniconazole and their metal salts and acid adducts, and also their mixtures.
Suitable imidazoles are preferably compounds such as imazalil, pefurazoate, prochloraz, triflumizole, bifonazole, canesten, fluotimazole, miconazole, econazole, isoconazole, sulconazole and their metal salts and adducts and also their mixtures.
Suitable benzimidazoles are preferably compounds such as methyl benzimidazolyl-carbamate (MBC), benomyl, fuberidazole and thiabendazole.
Suitable morpholine derivatives are preferably compounds such as tridemorph, aldimorph, fenpropimorph, amorolfine and dodemorph.
Combinations of 3,5-dimethyl-4-chlorophenol, 2-benzyl-4-chlorophenol, p-chloro-m-cresol (CMC) and/or o-phenylphenol (OPP) as phenolic components and azoles such as tebuconazole, propiconazole, azaconazole, cyproconazole, climbazole, hexaconazole, epoxyconazole and/or imazalil as further components are preferred.
Combinations of the abovementioned preferred phenols with benzimidazoles such as MBC, benomyl and/or aldimorph or tridemorph are furthermore preferred.
Combinations of CMC and/or OPP with tebuconazole and/or propiconazole are particularly preferred.
Also preferred combinations are combinations of OPP and/or CMC with MBC.
In particular, a mixture comprising CMC, OPP and tebuconazole is used.
The mixing ratios of the phenolic component to the other active compounds is generally 5 to 200, preferably 10 to 100, in particular 12 to 50, parts by weight to 1 part by weight.
The ratio of the phenolic compounds to each other can be varied within wide limits and is preferably 1:1 to 1:5 in the case of a mixture of OPP and CMC.
The abovementioned mixtures of the active compounds are generally employed in the form of formulations. The use concentration is preferably 0.1 to 1% of mixture of active compounds based on the hides or leather to be protected.
In the compositions resulting from the formulation, the mi

REFERENCES:
patent: 2904392 (1959-09-01), Pomerantz et al.
Derwent Abstract No. 95-118959 which is an abstract of Japanese Patent Specification No. 07-041800, Feb. 1995.
WPIDS Abstract No. 80-58956C which is an abstract of German Patent Specification No. 2904390, Aug. 1980.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of using a mixture of a phenolic compound and an azole or does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of using a mixture of a phenolic compound and an azole or, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using a mixture of a phenolic compound and an azole or will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1210988

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.